2024
1. Yu, J. et al. Efficacy of a surgical cardiac ablation clamp using nanosecond pulsed electric fields: An acute porcine model. J. Thorac. Cardiovasc. Surg. S0022-5223(24)00531–2 (2024) doi:10.1016/j.jtcvs.2024.06.009.
2. Tzeis, S. et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Eur. Eur. Pacing Arrhythm. Card. Electrophysiol. J. Work. Groups Card. Pacing Arrhythm. Card. Cell. Electrophysiol. Eur. Soc. Cardiol. 26, euae043 (2024).
3. Tzeis, S. et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm S1547-5271(24)00261–3 (2024) doi:10.1016/j.hrthm.2024.03.017.
4. Tzeis, S. et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. J. Interv. Card. Electrophysiol. Int. J. Arrhythm. Pacing 67, 921–1072 (2024).
5. Schumer, E. M. et al. Surgically implanted endovascular, microaxial left ventricular assist device: A single institution study. JTCVS Tech. 23, 63–71 (2024).
6. Schill, M. R. et al. Sinus Rhythm Atrial Electrocardiographic Imaging in Patients With Mitral Regurgitation: Clues to the Substrate for Atrial Fibrillation. Circ. Arrhythm. Electrophysiol. 17, e012666 (2024).
7. McGilvray, M. M. O. & Damiano, R. J. Reply from authors: The best patient for the operation, or the best operation for the patient? J. Thorac. Cardiovasc. Surg. 167, e41–e43 (2024).
8. McGilvray, M. M. O. et al. Surgical ablation for atrial fibrillation is efficacious in patients with giant left atria. J. Thorac. Cardiovasc. Surg. 167, 680-691.e2 (2024).
9. Altmayer, L. A. et al. A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing. Nutrients 16, 2134 (2024).
2023
10. Yates, T.-A. et al. Delayed-enhancement cardiac magnetic resonance imaging detects disease progression in patients with mitral valve disease and atrial fibrillation. JTCVS Open 16, 292–302 (2023).
11. Yates, T.-A. et al. Minimally Invasive Mitral Valve Surgery With Concomitant Cox Maze Procedure Is as Effective as a Median Sternotomy With Decreased Morbidity. Innov. Phila. Pa 18, 565–573 (2023).
12. Yates, T.-A. et al. Performance of an Irrigated Bipolar Radiofrequency Ablation Clamp on Explanted Human Hearts. Ann. Thorac. Surg. 116, 307–313 (2023).
13. Varghese, F., Philpott, J. M., Neuber, J. U., Hargrave, B. & Zemlin, C. W. Surgical Ablation of Cardiac Tissue with Nanosecond Pulsed Electric Fields in Swine. Cardiovasc. Eng. Technol. 14, 52–59 (2023).
14. Serra, F. et al. Nanosecond Pulsed Electric Field Ablation With a Bipolar Clamp Creates Durable Transmural Lesions in Cardiac Tissue. Circ. Arrhythm. Electrophysiol. 16, e012300 (2023).
15. Schumer, E. M. et al. Management of severe tricuspid valve regurgitation due to ruptured papillary muscle in a patient with mediastinitis early after heart transplant. JTCVS Tech. 21, 106–108 (2023).
16. Miller, P. C. et al. Outcomes of double-valve surgery for infective endocarditis are improving in the modern era. J. Thorac. Cardiovasc. Surg. S0022-5223(23)00898-X (2023) doi:10.1016/j.jtcvs.2023.09.072.
17. McGilvray, M. M. O. et al. An experimental model of chronic severe mitral regurgitation. JTCVS Tech. 20, 58–70 (2023).
18. McGilvray, M. M. O., Barron, L., Yates, T.-A. E., Zemlin, C. W. & Damiano, R. J. The Cox-Maze procedure: What lesions and why. JTCVS Tech. 17, 84–93 (2023).
19. Edgerton, J. R. & Damiano, R. J. Commentary: What is the measure of success for atrial fibrillation ablation? Is a reduction in arrhythmia burden sufficient? J. Thorac. Cardiovasc. Surg. 165, 1396–1397 (2023).
20. Chu, M. W. A. et al. Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial. Ann. Thorac. Surg. 115, 929–938 (2023).
21. Bakir, N. H. et al. Characterization of de novo malignancy after orthotopic heart transplantation: single-centre outcomes over 20 years. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 64, ezad341 (2023).
2022
22. Yates, T.-A. et al. Efficacy of a Novel Bipolar Radiofrequency Clamp: An Acute Porcine Model. Innov. Phila. Pa 17, 409–415 (2022).
23. Walker, K. L. et al. Cannulation Strategy for Extracorporeal Membrane Oxygenation Does Not Influence Total Hospital Cost. Ann. Thorac. Surg. 113, 49–57 (2022).
24. MacGregor, R. M. et al. Late results after stand-alone surgical ablation for atrial fibrillation. J. Thorac. Cardiovasc. Surg. 164, 1515-1528.e8 (2022).
25. Kunz, L. K., Scheibe, S., Wisse, B., Boerner, K. & Zemlin, C. From dementia mindsets to emotions and behaviors: Predicting person-centered care in care professionals. Dement. Lond. Engl. 21, 1618–1635 (2022).
26. Kachroo, P. et al. Association of STS database variables with repair durability in ischemic mitral regurgitation using machine learning. J. Card. Surg. 37, 76–83 (2022).
27. Jamieson, W. R. E. et al. PROSE: Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation: Part 2: Study results-prostheses, positions, and economic development. JTCVS Open 12, 51–70 (2022).
28. Finnan, M. J. et al. 30 Years of Heart Transplant: Outcomes After Mechanical Circulatory Support From a Single Center. Ann. Thorac. Surg. 113, 41–48 (2022).
29. Chu, M. W. A. et al. WITHDRAWN: Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Controlled Trial. Ann. Thorac. Surg. S0003-4975(22)00138–2 (2022) doi:10.1016/j.athoracsur.2022.01.015.
30. Bakir, N. H. et al. Concomitant Cox-Maze IV and Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy. Ann. Thorac. Surg. 113, 109–117 (2022).
31. Bakir, N. H. et al. Concomitant surgical ablation for atrial fibrillation is associated with increased risk of acute kidney injury but improved late survival. J. Thorac. Cardiovasc. Surg. 164, 1847-1857.e3 (2022).
32. Bakir, N. H. et al. Competing Risks to Transplant in Bridging With Continuous-flow Left Ventricular Assist Devices. Ann. Thorac. Surg. 114, 1276–1283 (2022).
2021
33. Zemlin, C. W. Safety factor for electrostimulation with nanosecond pulses. Bioelectrochemistry Amst. Neth. 141, 107882 (2021).
34. Sözer, E. B. et al. Analysis of electrostimulation and electroporation by high repetition rate bursts of nanosecond stimuli. Bioelectrochemistry Amst. Neth. 140, 107811 (2021).
35. Neuber, J. U., Pakhomov, A. G. & Zemlin, C. W. Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts. PloS One 16, e0257287 (2021).
36. Moreno, J. D., Bach, R. G., Damiano, R. J., Martinez, S. C. & Cresci, S. Phenylephrine Provocation to Evaluate the Cause of Mitral Regurgitation in Patients With Obstructive Hypertrophic Cardiomyopathy. Circ. Cardiovasc. Imaging 14, e012656 (2021).
37. McGilvray, M. M. O. et al. Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 32, 2884–2894 (2021).
38. MacGregor, R. M. et al. Impact of Obesity on Atrial Fibrillation Recurrence Following Stand-Alone Cox Maze IV Procedure. Innov. Phila. Pa 16, 434–440 (2021).
39. Jamieson, W. R. E. et al. PROSE: Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation : Part 1(Patient Dynamics): Preoperative demographics and preoperative and operative risk factors. J. Cardiothorac. Surg. 16, 323 (2021).